University College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Sheffield Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
"apoptosis"×
10 miles

apoptosis PhD Projects, Programs & Scholarships

We have 27 apoptosis PhD Projects, Programs & Scholarships

  • "apoptosis" ×
  • clear all
Order by 
Showing 1 to 10 of 27
  Application of data science to inherited genetic variants of apoptosis genes and susceptibility to breast cancer
  Prof A Cox, Dr K Walters
Applications accepted all year round

Funding Type

PhD Type

Background. The identification of the breast and ovarian cancer genes BRCA1 and BRCA2 two decades ago has resulted in both improved patient risk assessment and the use of PARP-inhibitors for treatment.
  Melanocyte proliferation and apoptosis in human skin: lessons from chronic plaque psoriasis
  Prof DJ Tobin
Application Deadline: 16 November 2019

Funding Type

PhD Type

A PhD position is now available in the Charles Institute of Dermatology to investigate how epidermis remodeling in the common skin disorder Psoriasis may regulate melanocyte number.
  Inhibiting cell metabolism to enhance tumour cell death
  Dr C Bubici, Dr S Papa
Application Deadline: 31 January 2020

Funding Type

PhD Type

As you read this, millions of your cells from your body are dying. Do not panic – this is not bad news. Most of them are either superfluous or potentially harmful, so you are better off without them.
  Analysis of the role of microRNAs in the regulation of NF-kappaB dynamics and function
  Prof M White, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

NF-κB is one of most important cell signalling systems in the body and controls inflammation and cell fate. NF-κB signalling involves complex dynamics involving oscillations of the NF-κB complex between the nucleus and cytoplasm in activated cells.
  Targeting addiction to a breast cancer metastasis survival pathway by inhibition of RAN GTPase
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Prof M El-Tanani, Dr S Betmouni
Applications accepted all year round

Funding Type

PhD Type

Metastatic cancer is a major global health burden. Each year, eleven million new cases of cancer are diagnosed worldwide, including 5 million cases in industrialized countries.
  Identifying novel drug combinations to improve personalised therapy in cancer
  Dr S Varadarajan
Applications accepted all year round

Funding Type

PhD Type

Failure of chemotherapeutic agents to kill cancer cells is attributed to resistance mechanisms acquired by the cancer cells, often through evasion of apoptosis.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
  HDAC inhibitors: a potential therapy for breast cancer?
  Dr C Staton, Dr B Corfe
Applications accepted all year round

Funding Type

PhD Type

Radiation resistance, due to hypoxia, remains a major cause of mortality in the treatment of breast cancer.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Endothelial receptor antagonists in experimental models of pulmonary hypertension: Cellular and right ventricular studies.
  Dr D Welsh, Dr Y Dempsie
Applications accepted all year round

Funding Type

PhD Type

Project reference number. SHLS19004. Pulmonary hypertension (PH) is a general name for a group of progressive vasculopathies of the pulmonary vasculature.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.